RIVAXEL 1.5 MG 28 CAP

About rivastigmine central reversible non-competitive anticholinesterase, antidementia. The mechanism of action of rivastigmine Alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. it increases the concentration of acetylcholine through reversible inhibition of the acetylcholinesterase enzyme, which is involved in the hydrolysis of acetylcholine. It leads to an increased concentration of acetylcholine. These increased acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with rivastigmine. indications for rivastigmine1. Mild to moderate dementia of the Alzheimer’s type.